!-- notag -->
!-- notag -->
!-- notag -->
Press Releases - 2017 - Sanofi
Worldwide presence
English
English
français
Media
MMMM D, YYYY
Press Releases 2017
Home
Media
Press releases
2017
Press Releases - 2017
Facebook
Twitter
LinkedIn
Download the PDF version
2017-12-18
MMMM DD YYYY
Press releases
Sanofi and Alnylam submit Marketing Authorization Application to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis
Download the PDF version
2017-12-15
MMMM DD YYYY
Press releases
Sanofi: FDA lifts clinical hold on fitusiran
Download the PDF version
2017-12-13
MMMM DD YYYY
Press releases
Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma
Download the PDF version
2017-12-11
MMMM DD YYYY
Press releases
FDA Approves Sanofi's Admelog® (insulin lispro injection)
Download the PDF version
2017-12-04
MMMM DD YYYY
Press releases
Sanofi's Toujeo® met main objective in head-to-head study versus insulin degludec
Download the PDF version
2017-12-01
MMMM DD YYYY
Press releases
Sanofi ends development of Clostridium difficile vaccine
Download the PDF version
2017-11-30
MMMM DD YYYY
Press releases
Elias Zerhouni, President of Sanofi R&D, wins 'Executive of the Year' at annual Scrip Awards
Download the PDF version
2017-11-29
MMMM DD YYYY
Press releases
Sanofi updates information on dengue vaccine
Download the PDF version
2017-11-09
MMMM DD YYYY
Press releases
Sanofi, Principia agree to develop multiple sclerosis drug candidate
Download the PDF version
2017-11-02
MMMM DD YYYY
Press releases
Sanofi and Alnylam present positive complete results from APOLLO Phase 3 study of investigational patisiran in hereditary ATTR (hATTR) amyloidosis patients with polyneuropathy
Download the PDF version
2017-11-02
MMMM DD YYYY
Press releases
Sanofi : Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
Download the PDF version
2017-10-24
MMMM DD YYYY
Press releases
Sanofi Files Suit in the U.S. to Defend Its Patent Rights on Lantus® and Lantus® SoloStar®
Download the PDF version
2017-10-16
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis
Download the PDF version
2017-10-12
MMMM DD YYYY
Press releases
Sanofi invests €170 million in new vaccine production facility in France
Download the PDF version
2017-10-11
MMMM DD YYYY
Press releases
Sanofi: Availability of the Pre-quarterly Results Communication
Download the PDF version
2017-10-02
MMMM DD YYYY
Press releases
Sanofi Appoints Stefan Oelrich Executive Vice President Diabetes & Cardiovascular
Download the PDF version
2017-09-28
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce Approval of Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union
Download the PDF version
2017-09-20
MMMM DD YYYY
Press releases
Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy
Download the PDF version
2017-09-16
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce Positive Study Results for Dupixent® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis
Download the PDF version
2017-09-11
MMMM DD YYYY
Press releases
Sanofi, Regeneron: Dupilumab Hits Main Objectives in Late-Stage Asthma Trial
Download the PDF version
2017-09-08
MMMM DD YYYY
Press releases
Sanofi, Regeneron: Cemiplimab Receives FDA Breakthrough Designation for Advanced Cutaneous Squamous Cell Carcinoma
Download the PDF version
2017-09-07
MMMM DD YYYY
Press releases
Sanofi rated AA by Scope Ratings
Download the PDF version
2017-08-28
MMMM DD YYYY
Press releases
Sanofi completes the acquisition of Protein Sciences
Download the PDF version
2017-08-08
MMMM DD YYYY
Press releases
Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus®
Download the PDF version
2017-07-31
MMMM DD YYYY
Press releases
Sanofi: Online Availability of Sanofi Group's Half-Year Financial Report for 2017
Download the PDF version
2017-07-31
MMMM DD YYYY
Press releases
Sanofi Raises FY 2017 Business EPS(1) Guidance to Broadly Stable at CER(2)
Download the PDF version
2017-07-21
MMMM DD YYYY
Press releases
Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis
Download the PDF version
2017-07-18
MMMM DD YYYY
Press releases
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...
Download the PDF version
2017-07-12
MMMM DD YYYY
Press releases
Sanofi: Availability of the Pre-quarterly Results Communication
Download the PDF version
2017-07-11
MMMM DD YYYY
Press releases
Sanofi to acquire Protein Sciences
Download the PDF version
2017-07-10
MMMM DD YYYY
Press releases
Sanofi Genzyme and Alnylam Report Positive Results from Ongoing phase 2 Open-Label Extension Study with Investigational RNAi Therapeutic Fitusiran in Patients with Hemophilia A and B With or...
Download the PDF version
2017-06-27
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union
Download the PDF version
2017-06-15
MMMM DD YYYY
Press releases
Sanofi Launches "Action 2017", a Worldwide Employee Stock Purchase Plan
Download the PDF version
2017-06-14
MMMM DD YYYY
Press releases
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...
Download the PDF version
2017-06-11
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia
Download the PDF version
2017-05-22
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients
Download the PDF version
2017-05-19
MMMM DD YYYY
Press releases
Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
Download the PDF version
2017-05-10
MMMM DD YYYY
Press releases
Sanofi: Annual General Shareholders' Meeting of May 10, 2017
Download the PDF version
2017-04-28
MMMM DD YYYY
Press releases
Sanofi Delivers Robust Q1 2017 Financial Results
Download the PDF version
2017-04-28
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by US FDA
Download the PDF version
2017-04-24
MMMM DD YYYY
Press releases
Sanofi and Regeneron Receive CHMP Positive Opinion for Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
Download the PDF version
2017-04-14
MMMM DD YYYY
Press releases
Sanofi: Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the...
Download the PDF version
2017-04-11
MMMM DD YYYY
Press releases
Sanofi: Availability of the Pre-quarterly Results Communication
Download the PDF version
2017-04-05
MMMM DD YYYY
Press releases
Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee
Download the PDF version
2017-03-28
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce FDA Approval of Dupixent® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis
Download the PDF version
2017-03-04
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce Presentation of Positive Data from Long-Term Pivotal Phase 3 CHRONOS Study of Dupixent® (dupilumab) in Moderate-to-Severe Atopic Dermatitis
Download the PDF version
2017-03-03
MMMM DD YYYY
Press releases
Sanofi: Filing of the 2016 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report
Download the PDF version
2017-03-03
MMMM DD YYYY
Press releases
Sanofi Pasteur and MedImmune Collaborate on Monoclonal Antibody to Prevent Illnesses Associated with RSV
Download the PDF version
2017-03-02
MMMM DD YYYY
Press releases
Sanofi : Sanofi's Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charlès as New Independent Directors
Download the PDF version
2017-02-27
MMMM DD YYYY
Press releases
Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
Download the PDF version
2017-02-08
MMMM DD YYYY
Press releases
Sanofi: Appeals Court Grants Stay of Permanent Injunction for Praluent® (alirocumab) During Appeals Process
Download the PDF version
2017-02-08
MMMM DD YYYY
Press releases
Sanofi Delivers 2016 Sales and Business EPS(1) Growth at CER(2)
Download the PDF version
2017-02-01
MMMM DD YYYY
Press releases
Sanofi's Xyzal® Allergy 24HR Approved for Over-the-Counter Use in the United States
Download the PDF version
2017-02-01
MMMM DD YYYY
Press releases
Sanofi and Regeneron Announce First Approval of Kevzara(TM) (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients by Health Canada
Download the PDF version
2017-01-30
MMMM DD YYYY
Press releases
Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs
Download the PDF version
2017-01-23
MMMM DD YYYY
Press releases
Sanofi: Availability of the Pre-quarterly Results Communication
Download the PDF version
2017-01-17
MMMM DD YYYY
Press releases
Sanofi: SuliquaTM Approved in the European Union for the Treatment of Adults with Type 2 Diabetes
Download the PDF version
2017-01-06
MMMM DD YYYY
Press releases
Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection
Download the PDF version
2017-01-04
MMMM DD YYYY
Press releases
Sanofi Announces Soliqua(TM) 100/33 Now Available in the U.S.
Download the PDF version
2017-01-02
MMMM DD YYYY
Press releases
Sanofi Pasteur and MSD end joint vaccines business in Europe
Download the PDF version
2017-01-02
MMMM DD YYYY
Press releases
Sanofi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017
!-- notag -->